Article Versions Notes

De Kruijff IE, Timmermans AM, Den Bakker MA, Trapman-Jansen AMAC, Foekens R, Meijer-Van Gelder ME, Oomen-de Hoop E, Smid M, Hollestelle A, Van Deurzen CHM, et al. The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome. Cancers. 2018; 10(5):134. https://doi.org/10.3390/cancers10050134

De Kruijff, Ingeborg E., Anna M. Timmermans, Michael A. Den Bakker, Anita M.A.C. Trapman-Jansen, Renée Foekens, Marion E. Meijer-Van Gelder, Esther Oomen-de Hoop, Marcel Smid, Antoinette Hollestelle, Carolien H.M. Van Deurzen, and et al. 2018. "The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome" Cancers 10, no. 5: 134. https://doi.org/10.3390/cancers10050134

De Kruijff, I. E., Timmermans, A. M., Den Bakker, M. A., Trapman-Jansen, A. M. A. C., Foekens, R., Meijer-Van Gelder, M. E., Oomen-de Hoop, E., Smid, M., Hollestelle, A., Van Deurzen, C. H. M., Foekens, J. A., Martens, J. W. M., & Sleijfer, S. (2018). The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome. Cancers, 10(5), 134. https://doi.org/10.3390/cancers10050134